— Know what they know.
Not Investment Advice
Also trades as: PEAK (NYSE) · $vol 127M

DOC NYSE

Healthpeak Properties, Inc.
1W: +0.9% 1M: +20.3% 3M: +15.6% YTD: +22.7% 1Y: +16.9% 3Y: +13.6% 5Y: -21.9%
$19.73
+0.09 (+0.46%)
 
Weekly Expected Move ±9.6%
$16 $18 $19 $21 $23
NYSE · Real Estate · REIT - Healthcare Facilities · Alpha Radar Strong Buy · Power 71 · $13.6B mcap · 687M float · 1.21% daily turnover · Short 58% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
40.5 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 2.9%  ·  5Y Avg: 2.8%
Cost Advantage
41
Intangibles
14
Switching Cost
46
Network Effect
55
Scale ★
60
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. DOC shows a Weak competitive edge (40.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 2.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$19
Low
$20
Avg Target
$20
High
Based on 2 analysts since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 22Hold: 19Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$18.50
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-22 Morgan Stanley Ronald Kamdem $18 $20 +2 +1.5% $19.70
2026-05-13 UBS $17 $19 +2 -3.9% $19.78
2026-04-28 Morgan Stanley $21 $18 -3 +13.7% $15.83
2026-04-20 UBS Initiated $17 -2.1% $17.37
2026-02-03 Wells Fargo John Kilichowski $19 $18 -1 +6.4% $16.92
2026-01-09 Goldman Sachs Initiated $17 -0.2% $17.04
2026-01-05 Cantor Fitzgerald $20 $17 -3 +5.2% $16.16
2025-12-15 Jefferies $20 $17 -3 +2.0% $16.66
2025-12-15 Evercore ISI $22 $21 -1 +25.0% $16.80
2025-10-01 Cantor Fitzgerald Initiated $20 +4.4% $19.15
2025-09-15 Evercore ISI Initiated $22 +21.7% $18.08
2025-09-15 Raymond James Jonathan Hughes Initiated $20 +9.6% $18.25
2025-08-22 Morgan Stanley $16 $21 +4 +18.3% $17.75
2025-07-30 Robert W. Baird $24 $21 -3 +22.0% $17.22
2024-10-21 Deutsche Bank Omotayo Okusanya Initiated $28 +23.7% $22.64
2024-08-21 Citigroup Nick Joseph Initiated $22 +0.5% $21.89
2024-07-30 Robert W. Baird Wesley Golladay $22 $24 +2 +9.8% $21.85
2024-07-30 RBC Capital Michael Carroll $22 $25 +3 +14.4% $21.85
2024-05-03 Wedbush Richard Anderson Initiated $22 +14.8% $19.17
2024-04-10 RBC Capital Michael Carroll Initiated $22 +13.8% $19.34
2024-03-27 Robert W. Baird Initiated $22 +20.2% $18.31
2024-03-25 Wells Fargo Connor Siversky Initiated $19 +8.3% $17.54
2023-08-01 Credit Suisse Omotayo Okusanya Initiated $15 +2.5% $14.64
2022-08-31 Morgan Stanley $16 $16 +0 -2.7% $16.95
2022-07-15 Morgan Stanley $18 $16 -2 -4.5% $16.76
2022-07-11 Truist Financial $19 $17 -2 +2.5% $16.58
2022-06-30 Jefferies Initiated $20 +13.8% $17.58
2022-06-01 Morgan Stanley Initiated $18 -5.7% $18.55
2022-04-26 Barclays Initiated $20 +13.8% $17.58
2021-05-05 Truist Financial Michael R Lewis Initiated $19 +10.1% $17.26

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
May 22, 2026
DCF
4
ROE
3
ROA
3
D/E
2
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. DOC receives an overall rating of B-. Strongest factors: DCF (4/5). Areas of concern: D/E (2/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-04-24 B B-
2026-04-09 B- B
2026-04-07 B B-
2026-04-06 B- B
2026-04-01 C+ B-
2026-03-10 B- C+
2026-03-09 C+ B-
2026-03-06 B- C+
2026-02-24 C+ B-
2026-02-03 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

37 Grade B
Profitability
33
Balance Sheet
36
Earnings Quality
66
Growth
26
Value
41
Momentum
59
Safety
15
Cash Flow
75
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. DOC scores highest in Cash Flow (75/100) and lowest in Safety (15/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.42
Distress Zone
Piotroski F-Score
6/9
Beneish M-Score
-4.95
Unlikely Manipulator
Ohlson O-Score
-7.50
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB
Score: 40.7/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 5.55x
Accruals: -5.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. DOC scores 0.42, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. DOC scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. DOC's score of -4.95 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. DOC's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. DOC receives an estimated rating of BB (score: 40.7/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). DOC's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
61.74x
PEG
-0.22x
P/S
4.74x
P/B
1.75x
P/FCF
9.66x
P/OCF
9.26x
EV/EBITDA
11.95x
EV/Revenue
7.42x
EV/EBIT
30.28x
EV/FCF
18.04x
Earnings Yield
1.95%
FCF Yield
10.35%
Shareholder Yield
8.07%
Graham Number
$8.81
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 61.7x earnings, DOC is priced for high growth expectations. Graham's intrinsic value formula yields $8.81 per share, 124% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.861
NI / EBT
×
Interest Burden
0.366
EBT / EBIT
×
EBIT Margin
0.245
EBIT / Rev
×
Asset Turnover
0.143
Rev / Assets
×
Equity Multiplier
2.533
Assets / Equity
=
ROE
2.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. DOC's ROE of 2.8% is driven by a balanced combination of operating margin, asset efficiency, and leverage.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$2.72
Price/Value
6.05x
Margin of Safety
-504.86%
Premium
504.86%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with DOC's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. DOC trades at a 505% premium to its adjusted intrinsic value of $2.72, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 61.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$19.74
Median 1Y
$18.65
5th Pctile
$10.55
95th Pctile
$32.99
Ann. Volatility
32.4%
Analyst Target
$18.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Scott M. Brinker
President and Chief Executive Officer
$825,000 $7,208,688 $10,072,994
Kelvin O. Moses
Chief Financial Officer
$518,561 $2,256,379 $3,631,031
Thomas M. Klaritch
Former Chief Operating Officer
$450,000 $1,269,205 $2,943,223
Adam G. Mabry
Chief Investment Officer
$550,000 $1,496,788 $2,905,643
Scott R. Bohn
Chief Development Officer and Head of Lab
$550,000 $1,336,782 $2,602,679
Peter A. Scott
Former Chief Financial Officer
$174,811 $2,243,810 $2,441,733
Tracy A. Porter
EVP and General Counsel
$425,000 $1,203,801 $2,201,812

CEO Pay Ratio

46:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,072,994
Avg Employee Cost (SGA/emp): $219,990
Employees: 411

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
411
+6.2% YoY
Revenue / Employee
$6,867,426
Rev: $2,822,512,000
Profit / Employee
$173,594
NI: $71,347,000
SGA / Employee
$219,990
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 7.9% 9.7% 7.6% 6.5% 3.4% 7.9% 7.6% 8.3% 8.1% 3.7% 4.7% 3.0% 4.4% 4.8% 3.3% 3.8% 2.2% -0.5% 0.9% 2.8% 2.79%
ROA 3.4% 4.2% 3.2% 2.8% 1.4% 3.4% 3.2% 3.5% 3.4% 1.6% 1.9% 1.2% 1.8% 2.0% 1.4% 1.6% 0.9% -0.2% 0.4% 1.1% 1.10%
ROIC 1.9% 1.9% 2.7% 2.7% 2.7% 2.9% 2.7% 2.8% 2.8% 2.9% 3.4% 3.4% 3.5% 3.5% 2.7% 2.9% 3.0% 2.4% 2.9% 2.9% 2.94%
ROCE 1.0% 1.2% 2.1% 3.5% 2.8% 5.1% 4.9% 5.4% 5.3% 3.3% 3.6% 2.9% 3.8% 4.2% 2.9% 3.1% 2.5% 2.4% 2.8% 3.6% 3.64%
Gross Margin 60.1% 58.0% 58.8% 58.4% 58.5% 57.7% 58.0% 57.6% 59.3% 58.2% 59.5% 59.8% 60.6% 60.0% 60.3% 61.1% 60.2% 58.6% -87.2% -20.0% -19.97%
Operating Margin 19.0% 16.4% 16.5% 18.0% 18.8% 19.7% 12.8% 18.8% 18.3% 20.8% 21.5% 19.8% 16.0% 16.7% 17.6% 19.2% 18.9% 18.7% 20.3% 15.5% 15.54%
Net Margin 58.0% 11.4% 6.0% 14.4% 13.2% 68.0% 1.2% 22.6% 9.5% 11.5% 12.8% 1.1% 21.0% 12.3% 0.7% 6.1% 4.6% -16.6% 15.8% 25.7% 25.72%
EBITDA Margin 79.1% 56.4% 49.7% 58.0% 56.1% 1.1% 45.4% 68.5% 55.2% 54.4% 54.4% 49.9% 73.9% 64.6% 49.0% 56.3% 54.8% 57.3% 58.7% 76.6% 76.62%
FCF Margin 65.0% 61.4% 41.9% 44.7% 44.7% 45.4% 43.7% 42.1% 43.6% 43.3% 43.8% 41.3% 39.5% 39.8% 39.6% 42.8% 44.5% 43.3% 43.4% 41.2% 41.15%
OCF Margin 65.0% 61.4% 41.9% 44.7% 44.7% 45.4% 43.7% 42.1% 43.6% 43.3% 43.8% 41.3% 39.5% 39.8% 39.6% 42.8% 44.5% 44.3% 44.4% 42.9% 42.94%
ROE 3Y Avg snapshot only 3.11%
ROE 5Y Avg snapshot only 4.84%
ROA 3Y Avg snapshot only 1.24%
ROIC 3Y Avg snapshot only 2.02%
ROIC Economic snapshot only 2.86%
Cash ROA snapshot only 6.07%
Cash ROIC snapshot only 7.09%
CROIC snapshot only 6.79%
NOPAT Margin snapshot only 17.79%
Pretax Margin snapshot only 8.98%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 3.09%
SBC / Revenue snapshot only 0.50%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 27.50 22.53 30.21 34.22 50.81 19.65 22.41 18.45 17.65 35.95 31.16 52.07 43.56 47.70 54.53 48.06 71.52 -344.22 156.87 51.41 61.739
P/S Ratio 11.31 10.91 8.05 7.61 5.73 5.08 5.44 4.84 4.43 4.04 4.37 4.46 5.20 5.78 4.91 4.80 4.22 4.68 3.97 3.98 4.735
P/B Ratio 2.06 2.09 2.34 2.27 1.74 1.58 1.69 1.52 1.41 1.31 1.50 1.59 1.97 2.33 1.58 1.60 1.40 1.56 1.49 1.52 1.752
P/FCF 17.40 17.77 19.21 17.03 12.82 11.20 12.46 11.48 10.17 9.32 9.97 10.79 13.15 14.50 12.38 11.21 9.48 10.79 9.14 9.66 9.661
P/OCF 17.40 17.77 19.21 17.03 12.82 11.20 12.46 11.48 10.17 9.32 9.97 10.79 13.15 14.50 12.38 11.21 9.48 10.56 8.94 9.26 9.260
EV/EBITDA 25.10 24.38 22.14 17.82 16.10 11.84 12.83 11.45 10.88 12.75 13.04 14.12 13.73 13.84 13.76 13.10 13.18 14.46 13.16 11.95 11.950
EV/Revenue 16.54 15.91 11.33 10.82 8.87 8.16 8.66 8.02 7.57 7.12 7.57 7.54 8.09 8.50 8.21 7.98 7.40 7.86 7.47 7.42 7.423
EV/EBIT 134.35 115.14 75.05 44.38 46.52 24.13 26.25 22.33 21.54 33.21 32.02 40.83 35.83 36.27 40.03 37.39 42.98 48.80 38.77 30.28 30.275
EV/FCF 25.46 25.91 27.02 24.21 19.84 17.97 19.83 19.02 17.36 16.44 17.26 18.24 20.46 21.34 20.70 18.65 16.63 18.13 17.22 18.04 18.038
Earnings Yield 3.6% 4.4% 3.3% 2.9% 2.0% 5.1% 4.5% 5.4% 5.7% 2.8% 3.2% 1.9% 2.3% 2.1% 1.8% 2.1% 1.4% -0.3% 0.6% 1.9% 1.95%
FCF Yield 5.7% 5.6% 5.2% 5.9% 7.8% 8.9% 8.0% 8.7% 9.8% 10.7% 10.0% 9.3% 7.6% 6.9% 8.1% 8.9% 10.6% 9.3% 10.9% 10.4% 10.35%
Price/Tangible Book snapshot only 1.685
EV/OCF snapshot only 17.289
EV/Gross Profit snapshot only 391.811
Acquirers Multiple snapshot only 40.534
Shareholder Yield snapshot only 8.07%
Graham Number snapshot only $8.81
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.28 2.28 0.37 0.37 0.37 0.37 0.34 0.34 0.34 0.34 0.41 0.41 0.41 0.41 1.13 1.13 1.13 1.13 1.09 1.09 1.089
Quick Ratio 2.28 2.28 0.37 0.37 0.37 0.37 0.34 0.34 0.34 0.34 0.41 0.41 0.41 0.41 1.13 1.13 1.13 1.13 1.09 1.09 1.089
Debt/Equity 0.96 0.96 0.98 0.98 0.98 0.98 1.01 1.01 1.01 1.01 1.12 1.12 1.12 1.12 1.07 1.07 1.07 1.07 1.39 1.39 1.392
Net Debt/Equity 0.96 0.96 0.95 0.95 0.95 0.95 1.00 1.00 1.00 1.00 1.10 1.10 1.10 1.10 1.06 1.06 1.06 1.06 1.32 1.32 1.320
Debt/Assets 0.41 0.41 0.42 0.42 0.42 0.42 0.43 0.43 0.43 0.43 0.45 0.45 0.45 0.45 0.45 0.45 0.45 0.45 0.51 0.51 0.513
Debt/EBITDA 8.00 7.71 6.57 5.42 5.84 4.58 4.82 4.59 4.55 5.58 5.60 5.87 4.99 4.51 5.60 5.30 5.75 5.93 6.51 5.85 5.851
Net Debt/EBITDA 7.95 7.66 6.40 5.28 5.70 4.46 4.77 4.54 4.51 5.52 5.51 5.77 4.90 4.44 5.53 5.23 5.67 5.85 6.18 5.55 5.550
Interest Coverage 0.82 1.06 1.81 3.18 2.49 4.27 3.93 4.09 3.90 2.34 2.57 1.96 2.28 2.28 1.97 2.04 1.65 1.53 1.78 2.20 2.203
Equity Multiplier 2.36 2.36 2.34 2.34 2.34 2.34 2.37 2.37 2.37 2.37 2.47 2.47 2.47 2.47 2.37 2.37 2.37 2.37 2.71 2.71 2.711
Cash Ratio snapshot only 0.546
Debt Service Coverage snapshot only 5.580
Cash to Debt snapshot only 0.052
FCF to Debt snapshot only 0.113
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.08 0.09 0.12 0.12 0.13 0.13 0.13 0.13 0.14 0.14 0.14 0.14 0.15 0.16 0.15 0.16 0.16 0.16 0.14 0.14 0.143
Inventory Turnover
Receivables Turnover 28.21 29.54 41.69 42.64 43.56 44.41 40.36 40.90 41.44 42.14 39.92 41.41 44.15 46.79 40.72 42.17 42.16 42.24 7.42 7.55 7.548
Payables Turnover 0.91 0.96 3.11 3.22 3.32 3.39 3.50 3.56 3.59 3.64 3.57 3.65 3.85 4.04 4.16 4.28 4.29 4.33 4.40 5.67 5.668
DSO 13 12 9 9 8 8 9 9 9 9 9 9 8 8 9 9 9 9 49 48 48.4 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 400 378 117 114 110 108 104 102 102 100 102 100 95 90 88 85 85 84 83 64 64.4 days
Cash Conversion Cycle -387 -366 -108 -105 -102 -99 -95 -94 -93 -92 -93 -91 -86 -83 -79 -77 -76 -76 -34 -16 -16.0 days
Fixed Asset Turnover snapshot only 6.969
Cash Velocity snapshot only 5.342
Capital Intensity snapshot only 7.079
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -33.9% -26.3% 74.5% 67.0% 61.2% 57.0% 8.7% 7.7% 6.8% 6.5% 5.8% 8.3% 14.0% 18.8% 23.8% 23.6% 15.9% 9.6% 4.5% 2.7% 2.71%
Net Income 53.9% 1.0% 22.2% 53.9% -55.8% -16.1% -1.0% 27.0% 1.4% -53.8% -38.9% -64.6% -45.8% 28.1% -20.5% 44.2% -42.7% -1.1% -70.7% -20.5% -20.46%
EPS 52.1% 1.0% 22.0% 53.7% -55.4% -17.1% -0.8% 25.2% 1.3% -53.9% -39.9% -67.8% -57.8% 0.2% -37.8% 24.0% -42.2% -1.1% -70.5% -20.0% -20.01%
FCF 1.6% 4.3% 4.9% 10.3% 10.9% 16.1% 13.2% 1.5% 4.2% 1.6% 6.2% 6.2% 3.4% 9.3% 11.9% 28.1% 30.6% 19.2% 14.4% -1.3% -1.27%
EBITDA -30.6% -30.9% -6.3% 58.1% 34.8% 65.9% 43.3% 24.2% 34.9% -13.7% -9.0% -17.4% -3.6% 30.7% 27.3% 41.1% 10.6% -3.1% -0.5% 4.7% 4.74%
Op. Income 38.3% 51.2% 70.6% 15.1% 8.9% 15.6% 4.8% 8.0% 6.5% 3.3% 21.7% 24.5% 26.7% 22.6% 8.6% 6.7% 8.4% 11.3% 15.5% 8.3% 8.25%
OCF Growth snapshot only 3.01%
Asset Growth snapshot only 1.99%
Equity Growth snapshot only -10.73%
Debt Growth snapshot only 15.71%
Shares Change snapshot only -0.56%
Dividend Growth snapshot only 0.42%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -12.7% -11.4% 0.9% 2.4% 2.8% 1.9% 1.1% 2.4% 4.4% 7.2% 26.1% 24.9% 25.2% 25.7% 12.5% 13.0% 12.2% 11.5% 11.0% 11.2% 11.21%
Revenue 5Y -12.4% -10.6% 1.5% 2.3% 3.7% 5.1% 2.2% 2.6% 2.8% 3.1% 3.4% 4.6% 5.7% 6.0% 6.2% 7.6% 8.5% 9.9% 21.0% 19.9% 19.86%
EPS 3Y 89.7% 47.0% -24.9% -29.3% -41.3% -17.4% 1.2% 25.1% 16.8% -8.5% -10.0% -14.8% -23.9% -27.4% -28.2% -20.6% -17.0% -52.0% -31.7% -31.66%
EPS 5Y -6.9% -17.1% -22.4% -3.3% 1.0% 48.2% 4.0% -24.0% -32.3% -27.5% -23.6% 30.7% -4.8% -17.2% -33.2% -9.3% -9.29%
Net Income 3Y 99.3% 53.9% -21.9% -26.4% -38.9% -14.4% 1.2% 27.7% 17.4% -8.0% -9.6% -11.6% -17.1% -20.8% -21.7% -13.5% -9.6% -47.8% -26.0% -25.98%
Net Income 5Y -4.2% -15.0% -20.2% -0.3% 3.9% 52.8% 7.2% -22.0% -29.1% -21.7% -18.0% 39.8% 1.2% -12.9% -29.6% -4.5% -4.54%
EBITDA 3Y -3.7% -6.1% -19.7% -14.2% -14.9% -5.8% 14.1% 11.1% 8.1% -0.4% 6.9% 17.5% 20.6% 23.2% 18.4% 13.1% 12.9% 3.0% 4.9% 6.9% 6.87%
EBITDA 5Y -0.5% 2.5% -1.8% -3.7% -1.8% 5.3% 2.1% 12.0% 10.2% 3.5% -7.6% -8.3% -4.3% -1.2% 11.4% 9.8% 6.1% 4.6% 9.1% 19.1% 19.10%
Gross Profit 3Y -7.8% -5.9% -0.6% 1.1% 2.2% 2.3% 2.3% 6.7% 9.1% 11.8% 21.6% 16.7% 17.0% 17.9% 13.1% 14.1% 13.4% 12.6% -19.1% -64.4% -64.43%
Gross Profit 5Y -11.8% -9.5% 1.8% 2.4% 3.8% 5.1% 0.3% 0.9% 1.4% 2.2% 2.3% 4.0% 5.8% 6.9% 7.8% 11.2% 12.3% 13.4% -2.3% -42.2% -42.18%
Op. Income 3Y -13.8% -12.0% -11.8% -10.7% -7.0% -3.1% -0.8% 13.9% 17.1% 21.8% 29.6% 15.7% 13.7% 13.5% 11.5% 12.8% 13.5% 12.1% 15.1% 12.9% 12.87%
Op. Income 5Y -21.1% -18.2% -1.1% -0.9% 2.1% 5.0% -8.6% -6.7% -5.7% -4.1% -2.6% -0.8% 1.6% 2.9% 5.2% 14.5% 17.1% 19.8% 22.2% 12.3% 12.32%
FCF 3Y -2.3% -2.1% -2.1% 2.2% 3.9% 2.8% 2.1% 4.0% 5.5% 7.2% 8.0% 5.9% 6.1% 8.8% 10.4% 11.4% 12.0% 9.8% 10.8% 10.3% 10.34%
FCF 5Y -9.2% -10.2% -8.1% -5.3% -2.0% 1.5% 1.2% 0.7% 1.5% 2.0% 2.4% 2.9% 3.8% 3.8% 4.8% 8.9% 9.6% 9.9% 10.1% 8.5% 8.50%
OCF 3Y -2.3% -2.1% -2.1% 2.2% 3.9% 2.8% 2.1% 4.0% 5.5% 7.2% 8.0% 5.9% 6.1% 8.8% 10.4% 11.4% 12.0% 10.6% 11.6% 11.9% 11.91%
OCF 5Y -9.2% -10.2% -8.1% -5.3% -2.0% 1.5% 1.2% 0.7% 1.5% 2.0% 2.4% 2.9% 3.8% 3.8% 4.8% 8.9% 9.6% 10.4% 10.5% 9.4% 9.43%
Assets 3Y 56.4% 56.4% 54.4% 54.4% 54.4% 54.4% 4.0% 4.0% 4.0% 4.0% -0.5% -0.5% -0.5% -0.5% 9.3% 9.3% 9.3% 9.3% 8.8% 8.8% 8.84%
Assets 5Y 57.5% 57.5% 39.5% 39.5% 39.5% 39.5% 30.5% 30.5% 30.5% 30.5% 30.5% 30.5% 30.5% 30.5% 7.3% 7.3% 7.3% 7.3% 5.0% 5.0% 5.02%
Equity 3Y 39.6% 39.6% 39.9% 39.9% 39.9% 39.9% 3.0% 3.0% 3.0% 3.0% -1.9% -1.9% -1.9% -1.9% 8.8% 8.8% 8.8% 8.8% 4.1% 4.1% 4.07%
Book Value 3Y 32.9% 33.4% 34.5% 34.5% 34.4% 35.1% 0.6% 1.0% 2.5% 2.5% -2.5% -5.5% -9.9% -10.1% -0.2% -0.2% -0.1% 0.4% -4.5% -3.9% -3.92%
Dividend 3Y -6.0% -8.1% -9.8% -8.9% -7.4% -5.3% -2.5% -2.0% -0.4% -0.3% -0.1% -3.3% -5.8% -4.1% -2.3% -0.2% -2.4% -3.9% -6.2% -7.5% -7.54%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.82 0.86 0.04 0.01 0.00 0.03 0.01 0.03 0.06 0.11 0.24 0.34 0.40 0.40 0.59 0.70 0.86 0.94 0.96 0.97 0.965
Earnings Stability 0.13 0.30 0.07 0.11 0.07 0.03 0.02 0.01 0.00 0.00 0.14 0.31 0.37 0.47 0.04 0.00 0.17 0.47 0.73 0.19 0.186
Margin Stability 0.86 0.86 0.94 0.87 0.87 0.87 0.93 0.87 0.87 0.87 0.95 0.90 0.90 0.90 0.97 0.94 0.93 0.94 0.67 0.45 0.450
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.91 0.50 0.50 0.94 1.00 0.89 0.50 0.50 0.84 0.50 0.82 0.89 0.92 0.82 0.83 0.20 0.50 0.92 0.918
Earnings Smoothness 0.58 0.33 0.80 0.58 0.23 0.82 0.99 0.76 0.18 0.26 0.52 0.05 0.41 0.75 0.77 0.64 0.46 0.00 0.77 0.772
ROE Trend -0.16 -0.11 0.04 0.02 -0.03 0.01 0.01 0.03 0.03 -0.05 -0.03 -0.04 -0.01 -0.01 -0.03 -0.02 -0.04 -0.05 -0.03 -0.00 -0.002
Gross Margin Trend 0.18 0.18 -0.02 -0.03 -0.04 -0.04 -0.04 -0.08 -0.08 -0.07 -0.00 0.01 0.01 0.02 0.02 0.02 0.02 0.01 -0.37 -0.58 -0.580
FCF Margin Trend 0.22 0.18 -0.14 -0.09 -0.09 -0.07 -0.12 -0.14 -0.11 -0.10 0.01 -0.02 -0.05 -0.05 -0.04 0.01 0.03 0.02 0.02 -0.01 -0.009
Sustainable Growth Rate -3.4% -1.0% -2.2% -3.3% -6.4% -1.9% -2.2% -1.5% -1.8% -6.3% -5.4% -7.1% -6.4% -6.8% -7.5% -7.7% -9.2% -9.8% -7.9% -7.87%
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.58 1.27 1.57 2.01 3.96 1.75 1.80 1.61 1.74 3.86 3.12 4.83 3.31 3.29 4.40 4.29 7.55 -32.61 17.55 5.55 5.552
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.98 0.98 0.96 0.958
FCF/Net Income snapshot only 5.322
OCF/EBITDA snapshot only 0.691
CapEx/Revenue 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.0% 1.0% 1.8% 1.78%
CapEx/Depreciation snapshot only 0.047
Accruals Ratio -0.02 -0.01 -0.02 -0.03 -0.04 -0.03 -0.03 -0.02 -0.03 -0.04 -0.04 -0.05 -0.04 -0.05 -0.05 -0.05 -0.06 -0.07 -0.06 -0.05 -0.050
Sloan Accruals snapshot only -0.055
Cash Flow Adequacy snapshot only 1.372
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 5.2% 4.9% 4.3% 4.4% 5.7% 6.3% 5.8% 6.4% 6.9% 7.5% 6.9% 6.5% 5.6% 5.1% 6.0% 6.3% 7.2% 6.5% 7.6% 7.4% 6.18%
Dividend/Share $1.33 $1.27 $1.20 $1.20 $1.20 $1.19 $1.20 $1.19 $1.19 $1.19 $1.20 $1.09 $1.00 $1.07 $1.14 $1.21 $1.21 $1.22 $1.22 $1.22 $1.22
Payout Ratio 1.4% 1.1% 1.3% 1.5% 2.9% 1.2% 1.3% 1.2% 1.2% 2.7% 2.1% 3.4% 2.4% 2.4% 3.3% 3.0% 5.1% 11.9% 3.8% 3.82%
FCF Payout Ratio 90.8% 87.0% 81.7% 74.9% 73.3% 70.8% 72.0% 73.8% 70.7% 70.2% 68.7% 70.2% 73.8% 73.6% 74.2% 70.5% 67.9% 69.8% 69.3% 71.7% 71.70%
Total Payout Ratio 1.5% 1.1% 1.3% 1.5% 3.0% 1.4% 1.4% 1.3% 1.3% 2.7% 2.2% 3.9% 3.0% 3.0% 4.1% 3.4% 5.8% 13.3% 4.1% 4.15%
Div. Increase Streak 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1
Chowder Number 0.01 -0.06 -0.13 -0.10 -0.05 0.01 0.05 0.06 0.07 0.08 0.08 0.08 0.14 0.20 0.27 0.35 0.27 0.20 0.14 0.08 0.078
Buyback Yield 0.1% 0.1% 0.1% 0.1% 0.1% 0.7% 0.6% 0.6% 0.7% 0.1% 0.1% 1.0% 1.4% 1.3% 1.4% 0.8% 1.0% 0.7% 0.9% 0.6% 0.64%
Net Buyback Yield 0.1% 0.0% 0.1% 0.1% 0.1% 0.7% -2.1% -2.4% -2.6% -3.5% 0.1% 1.0% 1.4% 1.3% 1.4% 0.8% 1.0% 0.7% 0.9% 0.6% 0.63%
Total Shareholder Return 5.3% 4.9% 4.3% 4.5% 5.8% 7.0% 3.6% 4.0% 4.3% 4.1% 7.0% 7.5% 7.0% 6.4% 7.4% 7.1% 8.2% 7.2% 8.4% 8.1% 8.05%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) -7.34 -187.31 3.76 1.30 0.96 0.99 0.98 0.96 0.95 0.89 0.94 0.91 0.93 0.92 0.90 0.93 0.89 1.83 0.65 0.86 0.861
Interest Burden (EBT/EBIT) -0.45 -0.02 0.47 0.70 0.61 0.77 0.75 0.76 0.75 0.59 0.63 0.51 0.57 0.56 0.49 0.50 0.38 -0.05 0.20 0.37 0.366
EBIT Margin 0.12 0.14 0.15 0.24 0.19 0.34 0.33 0.36 0.35 0.21 0.24 0.18 0.23 0.23 0.21 0.21 0.17 0.16 0.19 0.25 0.245
Asset Turnover 0.08 0.09 0.12 0.12 0.13 0.13 0.13 0.13 0.14 0.14 0.14 0.14 0.15 0.16 0.15 0.16 0.16 0.16 0.14 0.14 0.143
Equity Multiplier 2.34 2.34 2.35 2.35 2.35 2.35 2.36 2.36 2.36 2.36 2.42 2.42 2.42 2.42 2.42 2.42 2.42 2.42 2.53 2.53 2.533
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.93 $1.16 $0.94 $0.80 $0.41 $0.96 $0.93 $1.00 $0.97 $0.44 $0.56 $0.32 $0.41 $0.44 $0.35 $0.40 $0.24 $-0.05 $0.10 $0.32 $0.32
Book Value/Share $12.36 $12.48 $12.08 $12.07 $12.07 $11.93 $12.36 $12.16 $12.16 $12.16 $11.60 $10.56 $9.03 $9.07 $12.01 $12.02 $12.05 $12.06 $10.78 $10.79 $13.03
Tangible Book/Share $11.41 $11.52 $11.11 $11.11 $11.11 $10.98 $11.58 $11.40 $11.40 $11.39 $11.03 $10.04 $8.58 $8.62 $10.84 $10.85 $10.88 $10.89 $9.74 $9.75 $9.75
Revenue/Share $2.26 $2.39 $3.51 $3.59 $3.67 $3.70 $3.83 $3.82 $3.87 $3.93 $3.98 $3.76 $3.43 $3.65 $3.86 $4.00 $4.01 $4.02 $4.06 $4.13 $4.13
FCF/Share $1.47 $1.46 $1.47 $1.61 $1.64 $1.68 $1.67 $1.61 $1.69 $1.70 $1.75 $1.56 $1.36 $1.45 $1.53 $1.71 $1.79 $1.74 $1.76 $1.70 $1.70
OCF/Share $1.47 $1.46 $1.47 $1.61 $1.64 $1.68 $1.67 $1.61 $1.69 $1.70 $1.75 $1.56 $1.36 $1.45 $1.53 $1.71 $1.79 $1.78 $1.80 $1.77 $1.77
Cash/Share $0.08 $0.08 $0.29 $0.29 $0.29 $0.29 $0.13 $0.13 $0.13 $0.13 $0.21 $0.20 $0.17 $0.17 $0.17 $0.17 $0.17 $0.17 $0.77 $0.77 $1.68
EBITDA/Share $1.49 $1.56 $1.80 $2.18 $2.02 $2.55 $2.58 $2.67 $2.69 $2.20 $2.31 $2.01 $2.02 $2.24 $2.30 $2.44 $2.25 $2.19 $2.30 $2.57 $2.57
Debt/Share $11.89 $12.01 $11.82 $11.81 $11.81 $11.67 $12.46 $12.26 $12.25 $12.25 $12.94 $11.78 $10.07 $10.12 $12.90 $12.91 $12.94 $12.96 $15.00 $15.02 $15.02
Net Debt/Share $11.81 $11.93 $11.52 $11.52 $11.52 $11.38 $12.32 $12.13 $12.12 $12.12 $12.73 $11.59 $9.90 $9.95 $12.73 $12.74 $12.77 $12.79 $14.23 $14.25 $14.25
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.420
Altman Z-Prime snapshot only 0.304
Piotroski F-Score 6 6 5 5 5 4 6 6 7 6 6 6 6 7 7 8 7 5 6 6 6
Beneish M-Score -2.46 -2.42 -1.71 -1.79 -1.72 -2.82 -2.62 -2.66 -2.72 -2.89 -2.96 -2.87 -2.89 -1.17 -1.12 -0.88 -0.95 -3.76 -4.95 -4.947
Ohlson O-Score snapshot only -7.503
ROIC (Greenblatt) snapshot only 1.41%
Net-Net WC snapshot only $-15.77
EVA snapshot only $-1229390783.32
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 32.74 37.36 26.55 36.06 30.21 38.39 36.59 39.86 39.49 34.78 32.30 29.77 32.66 40.64 39.62 43.29 38.41 40.91 34.17 40.66 40.661
Credit Grade snapshot only 12
Credit Trend snapshot only -2.628
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 52
Sector Credit Rank snapshot only 46

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms